Brief: Cure Pharmaceutical Reports Q2 2022 Results
02/09/2022 11:01
Sept 2 (Reuters) - Cure Pharmaceutical Holding Corp
CURR.PK :
* CURE PHARMACEUTICAL REPORTS SECOND QUARTER 2022 RESULTS
WITH
INCREASED SEQUENTIAL REVENUES AND STRONG MARGINS
Source text for Eikon: ID:nGNX83vm5y
Further company coverage: CURR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenir Wellness Solutions
See all newsBrief: Cure Pharmaceutical Reports Q2 2022 Results
Brief: Cure Pharmaceutical Announces Rob Davidson As New Chairman Of The Board And Appointment Of Rob Costantino As Member Of The Board And Audit Committee Chairman
Brief: Cure Pharmaceutical Holding Q1 Revenue $1.5 Million
Brief: CURE Pharmaceutical Augments Its Existing U.S. DEA License
Brief: Cure Pharmaceutical Receives FDA Approval For Its IND Application For Curefilm Blue